Renaissance Technologies LLC Decreases Holdings in LifeVantage Co. (NASDAQ:LFVN)

Renaissance Technologies LLC trimmed its holdings in LifeVantage Co. (NASDAQ:LFVN - Free Report) by 5.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 780,818 shares of the company's stock after selling 47,300 shares during the period. Renaissance Technologies LLC owned about 6.22% of LifeVantage worth $13,688,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the business. Copeland Capital Management LLC purchased a new position in LifeVantage during the 4th quarter worth $65,000. Hillsdale Investment Management Inc. boosted its holdings in LifeVantage by 7.3% during the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock worth $258,000 after purchasing an additional 1,000 shares during the last quarter. Barclays PLC grew its position in LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company's stock worth $507,000 after purchasing an additional 11,608 shares in the last quarter. HighTower Advisors LLC purchased a new stake in LifeVantage in the 3rd quarter valued at about $638,000. Finally, Ritholtz Wealth Management lifted its position in shares of LifeVantage by 65.2% during the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company's stock worth $830,000 after buying an additional 18,682 shares in the last quarter. 35.32% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at LifeVantage

In related news, Director Raymond B. Greer sold 8,000 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $20.15, for a total value of $161,200.00. Following the completion of the transaction, the director now directly owns 99,288 shares in the company, valued at approximately $2,000,653.20. The trade was a 7.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 20.65% of the company's stock.

LifeVantage Stock Performance

NASDAQ LFVN traded down $0.76 on Friday, hitting $13.43. 133,253 shares of the stock traded hands, compared to its average volume of 125,063. The business's fifty day moving average is $16.00 and its two-hundred day moving average is $16.28. LifeVantage Co. has a 12 month low of $5.22 and a 12 month high of $27.38. The firm has a market capitalization of $168.56 million, a price-to-earnings ratio of 23.98 and a beta of 0.75.

LifeVantage (NASDAQ:LFVN - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were paid a $0.04 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.16 annualized dividend and a yield of 1.19%. LifeVantage's dividend payout ratio is currently 28.57%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Lake Street Capital started coverage on LifeVantage in a report on Thursday, December 19th. They issued a "buy" rating and a $26.00 target price for the company. Craig Hallum assumed coverage on LifeVantage in a research report on Tuesday, January 14th. They set a "buy" rating and a $35.00 target price for the company.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.